Background: Timing of carotid endarterectomy (CEA) after onset of neurologic symptoms remains controversial. We assessed the association of CEA timing with postoperative outcomes.
Multiple randomized clinical trials have established the benefits of carotid endarterectomy (CEA) for neurologic symptomatic carotid artery stenosis.
1,2 CEA timing after the onset of neurologic symptoms, however, remains controversial. Traditionally, the timing of CEA depended on the stroke severity and plateauing/ normalization of the neurologic symptoms. The risk of recurrent stroke or transient ischemic attacks (TIAs) is highest in the first few days after a neurologic event, ranging between 5% and 10% after an index TIA event. [3] [4] [5] A recent systematic review reported that the risk of recurrent stroke 7 days from an index event can reach as high as 6.4% in the first 2 to 3 days, 20% in the first 7 days, and up to 26% in the first 14 days. 6 Prospective registries report a stroke rate of 2.7% on day 1, 5.3% on day 3, and 11.5% on day 14. 7 Current guidelines agree that CEA should be done within 14 days of the neurologic event as it is associated with the highest number of prevented strokes. 1, [8] [9] [10] [11] [12] This is particularly true for neurologically stable patients presenting with TIA or minor stroke; the risk of stroke or death is equivalent for CEA done <2 weeks from symptoms compared with CEA done $2 weeks. 13 It is unclear which time interval within this early period is most optimal for CEA to prevent stroke recurrence and to minimize the risk of procedural stroke. The lack of high-quality evidence and standardized definitions for what constitutes an "early" or "urgent" carotid intervention has contributed to conflicting results in the literature. The neurologic heterogeneity of patients' symptoms, the appropriate intensive medical therapy, and the varying surgical approaches have led to polarizing debates about CEA timing in patients who present with neurologic symptoms. There is increasing evidence to suggest a higher risk of perioperative stroke within the first 48 hours of the neurologic event, although some studies have indicated equivalent outcomes between early (<48 hours) and late CEA. [14] [15] [16] Despite the higher stroke risk with CEA during this early period, it may still be lower than the stroke risk associated with the natural progression of a symptomatic lesion without an intervention. 17 The purpose of this study was to assess the effect of CEA timing on postoperative outcomes in patients undergoing CEA within 1 month of stroke in the Vascular Study Group of New England (VSGNE).
METHODS
The VSGNE registry was queried from 2003 to 2014 to identify CEA procedures. This registry is a regional cooperative database created in 2002 as a quality improvement initiative to prospectively collect the data of patients for a variety of vascular procedures. 18 Currently, it consists of >35 academic and community hospitals with >170 participating physicians. Data were prospectively collected by trained nurses or clinical abstractors on >100 clinical and demographic variables. Details about the database have been previously published. 18 The Institutional Review Board of Boston University School of Medicine has approved the use of deidentified data for this study; no informed consent was required. The analysis included only CEA for symptomatic stroke with a known length of stay (LOS); asymptomatic, combined CEA and cases with missing LOS were excluded. We also excluded cases performed for minor or major strokes occurring >1 month from symptoms and cases performed for TIAs. Differentiation between TIAs and strokes is according to the treating physician and the available clinical information. The VSGNE database consists of physician-reported information and does not require uniform or standardized assessment of a preoperative TIA or stroke. The study sample, therefore, consisted of CEA procedures performed for minor or major strokes occurring within 1 month before presentation. Primary outcomes included 30-day postoperative death (POD), in-hospital postoperative stroke and myocardial infarction (MI), combined postoperative MI or stroke, combined stroke/MI and death/stroke/MI end points, and discharge to nursing home. Secondary outcomes included 1-year ipsilateral stroke-free survival and any stroke-free survival rates.
Two groups were identified: the in-hospital group, who had surgery while in the hospital (patients whose LOSs were longer than the recorded days from surgery to discharge [LOS2]); and the delayed group, which included patients who had CEA the same day as admission. The in-hospital sample was further divided into three groups based on the difference between LOS and LOS2, assuming that this time corresponds to the onset of neurologic symptoms and the CEA: group I (<2 days), group II (2-5 days), and group III ($6 days). The decision of grouping was based on multiple studies and meta-analyses comparing the initial 48-hour period with later time points. 6, 19, 20 There is, however, a lack of consensus with regard to later time points. This is the result of the continuous change in practice guidelines and the need for earlier CEA. Group IV was the delayed group (same-day CEA). Group IV consisted of patients who had CEA on the day of admission, which we considered as more likely being a readmission for a planned repair (within 30 days of symptom onset). We assumed that a patient cannot be admitted for stroke, discharged, and readmitted for CEA in #5 days from the index event.
Given the possibility of an overlap between groups III and IV, a secondary analysis was performed combining the two groups. Recommendation: This study suggests that carotid endarterectomy in patients with minor or major stroke can be performed beyond the first 48 hours but in the first week after symptoms, with a low rate of in-hospital postoperative stroke.
RESULTS

Of 14,864
CEAs recorded in the VSGNE carotid database, 4076 cases were for symptomatic carotid stenosis. In this group, 989 cases satisfied our inclusion criteria and were included in this analysis. The in-hospital group included 512 cases: 96 (18.8%) in group I, 322 (62.9%) in group II, and 94 (18.4%) in group III. There were 477 patients who had same-day CEA as defined before (group IV). Fig 1 shows the trend toward more in-hospital CEA (P < .001). In 2014, 32.8% of CEA cases were performed in a delayed fashion. Group characteristics are listed in Table I . Group III had the highest rates of diabetes mellitus (44.7%; P ¼ .018), coronary artery disease (45.7%; P < .001), coronary artery bypass graft procedures (38.7%; P ¼ .001), congestive heart failure (17.0%; P ¼ .003), and American Society of Anesthesiologists class $3 (97.6%; P ¼ .006) and the highest modified Rankin score, which was available after September 2012 (1.6 6 1.5; P ¼ .015). Group I had the highest proportion of patients with >80% stenosis (77.8%; P ¼ .001) and using beta blockers (79.2%; P ¼ .002).
There were some minor differences in the surgical methodology; 90.6% of the CEA procedures were performed conventionally, and the other 9.4% had eversion endarterectomy. Of the patients who had conventional CEA, 88.5% had patch repair. Also, 47.5% of the conventional CEAs were performed with shunts. The majority of the procedures (90.1%) were performed under general anesthesia.
Outcomes. In-hospital mortality occurred in 8 (0.8%) patients, whereas in-hospital postoperative stroke occurred in 30 patients (3.0%) and 13 patients (1.3%) suffered from postoperative MI. The 30-day POD occurred in a total of 13 (1.3%) patients. The combined death, stroke, or MI outcome happened in 46 (4.7%) patients; 18.8% of patients were discharged to a nursing home. On univariate analysis, group I was associated with the highest stroke rate (7.3%), and this was significantly higher than in groups II (4.0%), III (2.1%), and IV (1.7%; P ¼ .016). The same holds true for the combined stroke/MI and death/stroke/MI end points, with higher rates in group I compared with the other groups (P < .05). Group III had the highest rate of discharges to nursing facilities, whereas group IV had the lowest rate of these discharges. The outcomes and crude comparisons across groups are summarized in Table II. Multivariate analysis comparing the association between demographics and outcomes of interest is depicted in Table III . Older age was significantly associated with increased odds of the combined stroke/ MI/POD end point (odds ratio [OR], 1.04; P ¼ .019). Betablocker use was significantly associated with increased odds of stroke (OR, 3.24; P ¼ .036) and the combined stroke/MI end point (OR, 3.3; P ¼ .018). Older age, female sex, diabetes status, and emergency cases were significant predictors of discharge to a nursing home. The adjusted association between time to CEA and postoperative outcomes is depicted in Fig 2. Group I had significantly higher adjusted odds of stroke (Fig 2, b) and the combined death/stroke/MI end point compared with group IV (OR, 3.3 [P ¼ .045] and OR, 1.4 [P ¼ .019], respectively). There was no statistically significant difference between group I and group IV in the POD (Fig 2, a) and MI (Fig 2, c) rates. Groups II and III had similar outcomes compared with group IV in terms of death, stroke, or MI rates. Groups I, II, and III had higher odds of being discharged to a nursing home (vs home) compared with group IV (ORs, 5.2, 5.2, and 8.6, respectively; P < .001). Kaplan-Meier analyses showed no difference in 1-year stroke-free survival rates between groups I, II, and III vs group IV (P > .05).
Secondary analysis. Combining groups III and IV, repeated analysis showed similar results. The three groups (I, II, III þ IV) were comparable in terms of diabetes mellitus, congestive heart failure, coronary artery bypass graft procedures, American Society of In-hospital % Delayed % Anesthesiologists class, and modified Rankin score (P > .05). Race, hypertension, coronary artery disease, beta-blocker use, urgency of procedure, and ipsilateral internal carotid artery stenosis were significantly different among the three groups (P < .05). On univariate analysis, group I had the highest stroke (7.3%), stroke/MI (9.4%), and death/stroke/MI (9.4%) rates (P < .05). The combined group had the lowest rate of discharge to a nursing home (12.3%; P < .05). On multivariable regression with the combined group as the reference category, group I had higher odds of postoperative stroke (OR, 3.1; P ¼ .042), whereas group II had similar odds of stroke (OR, 2.0; P ¼ .145). Similarly, group I had the highest odds of stroke/MI and death/stroke/MI end points. Groups I and II had higher odds of discharge to a nursing home with respective ORs of 2.3 (P ¼ .006) and 2.2 (P < .001). KaplanMeier analyses similarly did not show any difference in 1-year outcomes between the three groups (P > .05).
DISCUSSION
Analysis of the prospectively maintained VSGNE data set demonstrated an increasing trend of symptomatic CEAs performed during the index event admission. Our study indicated that CEA performed within the first 48 hours after onset of neurologic symptoms was associated with an increased risk of postoperative stroke, whereas CEA performed within 2 to 5 days had equivalent stroke risks compared with CEA performed later ($6 days). There were otherwise no differences between groups in overall stroke-free survival rates at 1 year.
American Heart Association guidelines state that perioperative stroke or mortality rates should be <6% for symptomatic carotid stenosis. 21 Whereas the overall cohort's stroke rate falls below that mark (3% vs 6%), CEA within the first 48 hours (group I) is associated with a 7.3% stroke rate. Expedited CEA within the first 14 days after onset of neurologic symptoms is recommended by societal guidelines, reflecting the increasing evidence that CEA performed within the first 14 days is more effective than deferred CEA in preventing a higher number of recurrent strokes. 8, 10, 22 Contemporary data are supporting CEA interventions at an even earlier period (within the first week); the United Kingdom guidelines recommend CEA within the first 48 hours. 10, [14] [15] [16] 20 Concerns with earlier CEA interventions arise from the risk of hemorrhagic conversion of an ischemic stroke, the increased susceptibility of infarcted brain tissue to additional ischemia from CEA, and the inherent plaque instability during the acute phase. 23 Yet, these concerns have not been consistently validated across the literature. Several studies show that the risk of stroke with CEA performed within the first week is equivalent to the risk with later CEA. 15, 16, 24 The equivalent stroke and death rates for CEA performed within the first, second, and third weeks of symptoms as opposed to later CEA were also reported in a review on neurologically stable patients presenting with TIA or stroke. 13 The Swedvasc registry study reported an elevated risk of stroke or death with CEA done #48 hours from the neurologic event (OR, 4.2; P < .001); our cohort's risk of stroke during this period was significantly greater than CEA performed $6 days after the event (OR, 3.1; P ¼ .042). 14 The elevated risk in that study has been attributed to the 12% incidence of crescendo TIA as the presenting neurologic event. This population of patients is inherently at a higher risk of stroke.
17
Our sample did not include TIAs, and nonetheless the same association between adverse outcomes and very early CEA was observed. Although there is significant variability in different studies in regard to the type of symptoms and intervention, the risk of stroke for CEA performed within the first 48-hour period ranges between 2.7% and 10.9% across studies and between 1.6% and 3.9% when CEA was performed within 3 to 7 days. [14] [15] [16] 20, 25 These ranges are comparable to the results we observed: 7.3% in group I and 4.0% in group II. Our results are also consistent with a recent metaanalysis showing the pooled 30-day stroke rate for CEA done within 2, 7, and 15 days from an index event (stroke or TIA) to be 5.3%, 3.2%, and 3.4%, respectively.
19,26 Our cohort's stroke rate was 7.3% for CEA in group I and 4.8% in group II. The literature and these results suggest that CEA can be performed safely shortly after the first 48 hours after a neurologic event. [14] [15] [16] 20 Intervening at an earlier period (#48 hours) may be acceptable in appropriately selected patients. For a TIA or minor stroke index event, some data suggest that CEA can be safely performed within 48 hours without an increased risk of complications. 25, 27 Other data suggest that this 48-hour early period for CEA is high risk and not as safe as CEA performed beyond this interval.
14 Despite the higher risk, proponents of early intervention argue that in the long run, a higher number of recurrent strokes would be prevented compared with operating beyond the first 48 hours. 12 The largest study to date examining >56,000 CEA procedures concluded that there is no difference in stroke and death outcomes among the different time intervals of carotid surgery. 20 Their results support our findings that intervening within 2 to 5 days is equivalent to a delayed intervention but go against our findings of a higher procedural stroke rate during the first 48 hours. 20 This is probably due to the different population of patients as our study excluded TIAs, whereas that study had >50% of their cohort having TIA as the index event. The type of acute presentation (TIA, minor or major stroke) correlates with the risk of periprocedural stroke. 25 There is a trend toward a higher ratio of in-hospital (groups I, II, and III) to later (group IV) CEA between 2003 and 2014 (Fig 1) . This highlights the increased awareness to perform earlier CEA after the onset of neurologic symptoms. Still, in 2014, the proportion of CEAs done on a second admission was around 30%. This suggests that there is a significant subset of CEA procedures being done in delayed fashion. It is possible that a significant portion of surgeons still have an unfounded fear of procedural strokes from early CEA. Early CEA should be considered an area for quality improvement in carotid-related symptomatic patients.
The results of the study need to be interpreted with caution. An important limitation is the inability to accurately account for the timing of neurologic events despite that our results closely match outcomes in the literature. Another assumption is that the physician's decision to delay the procedure (discharge and readmit the patient) would result in a CEA performed $6 days from the index neurologic event. Unavoidably, some patients may have been discharged and readmitted #5 days from symptoms, creating an overlap between groups. The delay between CEA and admission could be due to variables not captured by the VSGNE database, such as the availability of hospital personnel, the need for preoperative cardiac assessment, and the different approaches by practitioners across surgical specialties; this introduces the possibility of selection bias. Timing of CEA from TIA index events was not reliably accounted for, and thus those patients were excluded. Modified Rankin score, to quantify the degree of neurologic deficit, was added to the VSGNE database in 2012. Unfortunately, this important variable is missing for a large group of patients and was not included in our analyses. Excluding the 30-day mortality rate, all other outcomes included in-hospital rates. The discharge to a nursing home outcome may not always imply a severe stroke; it may be due to lack of social support at home, which cannot be extracted from the database. Discharge to a nursing home, however, is consistent with a higher degree of care than the patient can receive at his or her home after discharge. Appreciating that some social factors may lead to such discharge, most discharges to nursing homes are therefore indicative of the requirement of higher level of care and therefore worse outcome than discharge to home. There is also the potential for coding errors as the VSGNE consists of physician-entered data.
CONCLUSIONS
CEA performed <2 days from an index event carries a higher risk, whereas CEA within 2 to 5 days carries an equivalent risk compared with later CEA ($6 days) in neurologically stable stroke patients. Balancing the higher risk of postoperative stroke with the early risk of recurrent stroke is prudent to avoid repair within the first 2 days but still intervening within 1 week from neurologic symptoms. The advent of intense medical therapy is mitigating the risk of early recurrent stroke; thus, the impact of this on CEA timing remains unclear. The ideal timing for intervention should be determined on the basis of the individual patient and stroke characteristics until comparative trials are available.
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